224 related articles for article (PubMed ID: 23263460)
61. Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) patients are characterized by increased BDNF serum levels.
Angelucci F; Spalletta G; di Iulio F; Ciaramella A; Salani F; Colantoni L; Varsi AE; Gianni W; Sancesario G; Caltagirone C; Bossù P
Curr Alzheimer Res; 2010 Feb; 7(1):15-20. PubMed ID: 20205668
[TBL] [Abstract][Full Text] [Related]
62. Objective sleep duration is associated with cognitive deficits in primary insomnia: BDNF may play a role.
Fan TT; Chen WH; Shi L; Lin X; Tabarak S; Chen SJ; Que JY; Bao YP; Tang XD; Shi J; Lu L; Sun HQ; Liu JJ
Sleep; 2019 Jan; 42(1):. PubMed ID: 30346599
[TBL] [Abstract][Full Text] [Related]
63. Alcohol-induced cognitive deficits are associated with decreased circulating levels of the neurotrophin BDNF in humans and rats.
Silva-Peña D; García-Marchena N; Alén F; Araos P; Rivera P; Vargas A; García-Fernández MI; Martín-Velasco AI; Villanúa MÁ; Castilla-Ortega E; Santín L; Pavón FJ; Serrano A; Rubio G; Rodríguez de Fonseca F; Suárez J
Addict Biol; 2019 Sep; 24(5):1019-1033. PubMed ID: 30277635
[TBL] [Abstract][Full Text] [Related]
64. [EFFECTIVENESS OF CYTOFLAVIN FOR THE CORRECTION OF COGNITIVE IMPAIRMENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS].
Gatskikh IV; Veselova OF; Brikman IN; Shalda TP; Varygina EL; Kuznetsov MN; Shul'min AV; Petrova MM
Eksp Klin Farmakol; 2015; 78(11):21-5. PubMed ID: 27017701
[TBL] [Abstract][Full Text] [Related]
65. Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients.
Laske C; Stellos K; Hoffmann N; Stransky E; Straten G; Eschweiler GW; Leyhe T
Int J Neuropsychopharmacol; 2011 Apr; 14(3):399-404. PubMed ID: 20860877
[TBL] [Abstract][Full Text] [Related]
66. Association of early-onset Type 2 diabetes with cognitive impairment is partially mediated by increased pulse pressure.
Ang SF; Low SKM; Ng TP; Ang K; Yap PLK; Cheong CY; Lim Z; Tang WE; Moh AMC; Subramaniam T; Sum CF; Lim SC
J Diabetes Complications; 2022 Jul; 36(7):108209. PubMed ID: 35660335
[TBL] [Abstract][Full Text] [Related]
67. Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects.
Li G; Peskind ER; Millard SP; Chi P; Sokal I; Yu CE; Bekris LM; Raskind MA; Galasko DR; Montine TJ
PLoS One; 2009; 4(5):e5424. PubMed ID: 19412541
[TBL] [Abstract][Full Text] [Related]
68. Changes in the Brain-Derived Neurotrophic Factor Are Associated with Improvements in Diabetes Risk Factors after Exercise Training in Adolescents with Obesity: The HEARTY Randomized Controlled Trial.
Walsh JJ; D'Angiulli A; Cameron JD; Sigal RJ; Kenny GP; Holcik M; Doucette S; Alberga AS; Prud'homme D; Hadjiyannakis S; Gunnell K; Goldfield GS
Neural Plast; 2018; 2018():7169583. PubMed ID: 30363954
[TBL] [Abstract][Full Text] [Related]
69. Serum neurotrophin concentrations in polish adolescent girls with anorexia nervosa.
Dmitrzak-Weglarz M; Skibinska M; Slopien A; Tyszkiewicz M; Pawlak J; Maciukiewicz M; Zaremba D; Rajewski A; Hauser J
Neuropsychobiology; 2013; 67(1):25-32. PubMed ID: 23221923
[TBL] [Abstract][Full Text] [Related]
70. Serum brain-derived neurotrophic factor levels are specifically associated with memory performance among Alzheimer's disease cases.
O'Bryant SE; Hobson VL; Hall JR; Barber RC; Zhang S; Johnson L; Diaz-Arrastia R;
Dement Geriatr Cogn Disord; 2011; 31(1):31-6. PubMed ID: 21135555
[TBL] [Abstract][Full Text] [Related]
71. Sex differences in the association between serum BDNF and cognitive impairment in schizophrenia patients using various antipsychotics.
Dong R; Zhao NO; Wu HE; Yu L; Zhang XY
J Psychiatr Res; 2021 Jun; 138():492-499. PubMed ID: 33971483
[TBL] [Abstract][Full Text] [Related]
72. Association between Plasma Levels of PAI-1, tPA/PAI-1 Molar Ratio, and Mild Cognitive Impairment in Chinese Patients with Type 2 Diabetes Mellitus.
Wang J; Yuan Y; Cai R; Huang R; Tian S; Lin H; Guo D; Wang S
J Alzheimers Dis; 2018; 63(2):835-845. PubMed ID: 29689724
[TBL] [Abstract][Full Text] [Related]
73. High BDNF serum levels are associated to good cognitive functioning in bipolar disorder.
Mora E; Portella MJ; Piñol-Ripoll G; López R; Cuadras D; Forcada I; Teres M; Vieta E; Mur M
Eur Psychiatry; 2019 Aug; 60():97-107. PubMed ID: 30808582
[TBL] [Abstract][Full Text] [Related]
74. Diabetes and cognitive deficits in chronic schizophrenia: a case-control study.
Han M; Huang XF; Chen DC; Xiu M; Kosten TR; Zhang XY
PLoS One; 2013; 8(6):e66299. PubMed ID: 23840437
[TBL] [Abstract][Full Text] [Related]
75. Psychophysiological correlates of cognitive deficits in family caregivers of patients with Alzheimer Disease.
Corrêa MS; Vedovelli K; Giacobbo BL; de Souza CE; Ferrari P; de Lima Argimon II; Walz JC; Kapczinski F; Bromberg E
Neuroscience; 2015 Feb; 286():371-82. PubMed ID: 25490073
[TBL] [Abstract][Full Text] [Related]
76. Changes in plasma and cerebrospinal fluid biomarkers in aged patients with early postoperative cognitive dysfunction following total hip-replacement surgery.
Ji MH; Yuan HM; Zhang GF; Li XM; Dong L; Li WY; Zhou ZQ; Yang JJ
J Anesth; 2013 Apr; 27(2):236-42. PubMed ID: 23085747
[TBL] [Abstract][Full Text] [Related]
77. Study on caspase-1 and partial cognitive impairment in the comorbidity of type 2 diabetes and MDD.
Zhang X; Wang P; Shi L; Li N
J Affect Disord; 2021 Jul; 290():387-392. PubMed ID: 34087627
[TBL] [Abstract][Full Text] [Related]
78. Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia.
Asevedo E; Gadelha A; Noto C; Mansur RB; Zugman A; Belangero SI; Berberian AA; Scarpato BS; Leclerc E; Teixeira AL; Gama CS; Bressan RA; Brietzke E
J Psychiatr Res; 2013 Oct; 47(10):1376-82. PubMed ID: 23806580
[TBL] [Abstract][Full Text] [Related]
79. [The effects of dihydromyricetin on cognitive dysfunction in type 2 diabetes mice].
Zhu ZM; Yang JH; Yang SS; He JQ; Zhang KF; Feng SD; Ling HY
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 Apr; 33(4):323-328. PubMed ID: 29926637
[TBL] [Abstract][Full Text] [Related]
80. [Correlative study of the metabolic disorder of hippocampus and cerebral cortex and cognitive impairment in moderate to severe OSAHS patients].
Wang B; Xu X; Liang G; Zhang Y; Liu L; Zhang J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Apr; 29(7):607-11. PubMed ID: 26201184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
